Tae-young Ha

Incheon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Loss of miR-204 Drives NPTX1-Dependent Mitochondrial Dysfunction and Neuronal Degeneration in Alzheimer's Disease.

Loss of miR-204 Drives NPTX1-Dependent Mitochondrial Dysfunction and Neuronal Degeneration in Alzheimer's Disease.

Journal: Cellular and molecular neurobiology

Published: March 16, 2026

Microglia TFEB activation attenuates Alzheimer's disease pathology by enhancing autophagy-lysosomal function.

Microglia TFEB activation attenuates Alzheimer's disease pathology by enhancing autophagy-lysosomal function.

Journal: Journal of neuroinflammation

Published: October 10, 2025

GPR40 agonist ameliorates neurodegeneration by regulating mitochondria dysfunction and NLRP3 inflammasome in Alzheimer's disease animal models.

GPR40 agonist ameliorates neurodegeneration by regulating mitochondria dysfunction and NLRP3 inflammasome in Alzheimer's disease animal models.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 09, 2025

Investigation of Structural, Optical, Electrical, and Biological Properties of a Porous Platinum Electrode for Neurostimulation Devices.

Investigation of Structural, Optical, Electrical, and Biological Properties of a Porous Platinum Electrode for Neurostimulation Devices.

Journal: ACS applied bio materials

Published: April 04, 2025

Regulatory Mechanisms and Therapeutic Implications of Lysosomal Dysfunction in Alzheimer's Disease.

Regulatory Mechanisms and Therapeutic Implications of Lysosomal Dysfunction in Alzheimer's Disease.

Journal: International journal of biological sciences

Published: August 30, 2024

GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson's disease animal models.

GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson's disease animal models.

Journal: Pharmacological research

Published: March 29, 2024

Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson's disease.

Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson's disease.

Journal: Journal of neuroinflammation

Published: November 13, 2023

Scutellaria baicalensis Attenuated Neurological Impairment by Regulating Programmed Cell Death Pathway in Ischemic Stroke Mice.

Scutellaria baicalensis Attenuated Neurological Impairment by Regulating Programmed Cell Death Pathway in Ischemic Stroke Mice.

Journal: Cells

Published: July 21, 2023

Age-related increase in caveolin-1 expression facilitates cell-to-cell transmission of α-synuclein in neurons.

Age-related increase in caveolin-1 expression facilitates cell-to-cell transmission of α-synuclein in neurons.

Journal: Molecular brain

Published: May 18, 2021

DJ-1 deficiency impairs synaptic vesicle endocytosis and reavailability at nerve terminals.

DJ-1 deficiency impairs synaptic vesicle endocytosis and reavailability at nerve terminals.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 02, 2018

HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies.

HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies.

Journal: Biomolecules & therapeutics

Published: March 20, 2014

S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model.

S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model.

Journal: PloS one

Published: August 22, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026